Spago Nanomedical AB (publ)
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2017-10-20 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot | Subscription | 712 | 8,5 | SEK | 6 052 | 2017-10-17 |
| 2017-10-23 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Subscription | 712 | 8,5 | SEK | 6 052 | 2017-10-17 |
| 2018-02-19 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Return of loan increase | 17 000 | 0 | SEK | 0 | 2018-02-15 |
| 2018-08-29 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Loan granted | 780 000 | 0 | SEK | 0 | 2018-08-27 |
| 2018-09-11 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Return of loan increase | 780 000 | 0 | SEK | 0 | 2018-09-10 |
| 2018-09-12 | Spago Nanomedical AB (publ) | Mats Jörgen Zukunft Hansen | VD | Disposal | 129 031 | 0,77 | SEK | 99 353,87 | 2018-09-10 |
| 2018-09-13 | Spago Nanomedical AB (publ) | Mikael Lönn | Styrelseledamot | Acquisition | 33 515 | 0,77 | SEK | 25 806,55 | 2018-09-10 |
| 2018-09-25 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Dividend distributed | 797 220 | 12,85 | SEK | 10 244 277 | 2018-09-20 |
| 2018-09-25 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Dividend received | 797 220 | 12,85 | SEK | 10 244 277 | 2018-09-20 |
| 2018-10-03 | Spago Nanomedical AB (publ) | Mats Jörgen Zukunft Hansen | VD | Acquisition | 2 000 | 11,9 | SEK | 23 800 | 2018-10-02 |
| 2018-11-22 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Dividend distributed | 1 275 552 | 0,21 | SEK | 267 865,92 | 2018-11-20 |
| 2018-11-23 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Dividend received | 1 275 552 | 0,21 | SEK | 267 865,92 | 2018-11-20 |
| 2019-03-22 | Spago Nanomedical AB (publ) | Mats Jörgen Zukunft Hansen | VD | Exercise increase | 5 866 | 8,5 | SEK | 49 861 | 2019-03-19 |
| 2019-03-22 | Spago Nanomedical AB (publ) | Mats Jörgen Zukunft Hansen | VD | Exercise decrease | 29 330 | 0 | SEK | 0 | 2019-03-19 |
| 2019-03-23 | Spago Nanomedical AB (publ) | Mikael Lönn | Styrelseledamot/suppleant | Exercise increase | 320 000 | 8,5 | SEK | 2 720 000 | 2019-03-21 |
| 2019-03-24 | Spago Nanomedical AB (publ) | Hans Erik Oskar Axelsson | Forskningschef | Exercise increase | 9 412 | 8,5 | SEK | 80 002 | 2019-03-21 |
| 2019-03-27 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Exercise increase | 160 000 | 8,5 | SEK | 1 360 000 | 2019-03-24 |
| 2019-03-27 | Spago Nanomedical AB (publ) | Andreas Bunge | Styrelseledamot/suppleant | Exercise decrease | 800 000 | 0 | SEK | 0 | 2019-03-24 |
| 2019-05-20 | Spago Nanomedical AB (publ) | Nicklas Westerholm | Styrelseledamot/suppleant | Acquisition | 2 450 | 10,5 | SEK | 25 725 | 2019-05-16 |
| 2019-05-21 | Spago Nanomedical AB (publ) | Hanna Olsson | CFO | Acquisition | 2 000 | 10 | SEK | 20 000 | 2019-05-20 |